Stanford University


Showing 951-1,000 of 13,086 Results

  • Allison Betof, MD, PhD, FASCO

    Allison Betof, MD, PhD, FASCO

    Associate Professor of Medicine (Oncology)

    BioDr. Allison Betof is an Associate Professor of Medicine (Oncology), Director of the Melanoma Program, Director of Solid Tumor Cellular Therapy, and Mark & Mary Stevens Endowed Scholar in Melanoma at Stanford University School of Medicine. Dr. Betof completed her MD and PhD at Duke University, Internal Medicine residency at Massachusetts General Hospital (Harvard University) and Medical Oncology Fellowship at Memorial Sloan Kettering Cancer Center. Dr. Betof’s laboratory focuses on understanding resistance to immune checkpoint blockade and cellular therapies for melanoma and other solid tumors. She is the Principal Investigator of clinical trials exploring novel treatments for immunotherapy-refractory melanoma and is internationally recognized for her expertise in brain/CNS metastasis and the use of novel cellular therapies. Dr. Betof has been a pioneer in the use of commercial tumor infiltrating lymphocyte (TIL) therapy for the treatment of melanoma and other solid tumors. She has received funding and awards for her clinical and translational investigative work from multiple high-profile organizations, including the American Society of Clinical Oncology (ASCO), National Institutes of Health (NIH), Melanoma Research Alliance, and Melanoma Research Foundation.

  • Samuel Beuret

    Samuel Beuret

    Postdoctoral Scholar, Radiology

    BioI received the B.Sc., M.Sc., and Ph.D. degrees in Electrical Engineering from the École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland, in 2016, 2019, and 2024, respectively. After working as an Ultrasound Engineer at E-Scopics, Aix-en-Provence, France, I joined the Ultrasound Imaging and Instrumentation Lab of the Department of Radiology as a Postdoctoral Scholar in 2025. My research interests include signal processing, inverse problems, and probabilistic modeling applied to pulse-echo ultrasound imaging. My current work focuses on improving pulse-echo speed-of-sound imaging and distributed aberration correction.

  • Jill Beyer, OD

    Jill Beyer, OD

    Clinical Associate Professor, Ophthalmology

    BioJill Beyer, OD, is a Clinical Assistant Professor at Stanford University School of Medicine.

    Dr. Beyer graduated from Southern California College of Optometry, earning her Doctor of Optometry degree with distinction. She completed her residency at New England College of Optometry in Boston, Massachusetts, and earned a Bachelor of Science degree in Biology from Oregon State University.

    Jill’s residency education included time spent at the Boston Foundation for Sight, Massachusetts Eye and Ear Infirmary, Cornea Consultants & Boston Laser Center, and Harvard Vanguard Medical Associates.

    After residency training, Jill continued on as a clinical preceptor at the New England College of Optometry while working in private practice in Boston. She then transitioned to full time academic work at the Massachusetts Eye and Ear Infirmary becoming the Director of the Contact Lens Department and an Instructor in Ophthalmology at Harvard Medical School.

  • Gala Beykin, MD

    Gala Beykin, MD

    Clinical Instructor, Ophthalmology

    BioDr. Beykin is an ophthalmologist and glaucoma specialist at the Byers Eye Institute at Stanford Health Care. She is also a clinical instructor in the Department of Ophthalmology at Stanford University School of Medicine.

    Dr. Beykin completed clinical and surgical training in glaucoma at the Byers Eye Institute. She specializes in caring for patients with all types of ophthalmic conditions, including glaucoma and cataract.

    She has expertise in clinical trial design and implementation, and studies novel biomarkers and candidate therapeutics for vision protection and restoration in glaucoma. Her research efforts include numerous clinical trials investigating new therapies for eye conditions. Dr. Beykin has participated in multiple studies evaluating drugs targeting retinal disease such as AMD and diabetes-related vision loss, as well as ongoing clinical trials assessing new treatment strategies for neuroprotection, neuroregeneration and neuroenhancement in glaucoma. These include implants that could potentially stop or slow the progression of and help improve vision.

    Dr. Beykin has published her work in numerous peer-reviewed journals, including the British Journal of Ophthalmology and Investigative Ophthalmology & Visual Science. She has presented her work at national and international meetings, including those for the International Symposium on Retinal Degeneration and the Association for Research in Vision and Ophthalmology.

    She is a member of the Israeli Ophthalmology Society, the Israeli Society for Eye and Vision Research, and the Association for Research in Vision and Ophthalmology.

  • Vivek Bhalla, MD

    Vivek Bhalla, MD

    Associate Professor of Medicine (Nephrology)

    Current Research and Scholarly InterestsDr. Bhalla's two primary research interests are in the role of the kidney in diabetes and hypertension. We use molecular, biochemical, and transgenic approaches to study: (1) mechanisms diabetic kidney disease disease including the role of the endothelium to regulate inflammation and kidney injury; and (2) regulation of tubular transport of glucose, sodium, and potassium. These latter studies have treatment implications in diabetes, kidney disease, and hypertension.

  • Rashmi Parekh Bhandari

    Rashmi Parekh Bhandari

    Clinical Professor, Anesthesiology, Perioperative and Pain Medicine

    Current Research and Scholarly InterestsClinical interventions, treatments, and outcomes in pediatric pain management

  • Sushma Bharadwaj, MD

    Sushma Bharadwaj, MD

    Clinical Assistant Professor, Medicine - Blood & Marrow Transplantation

    BioDr. Bharadwaj is fellowship-trained in blood and marrow transplantation, cellular therapy, hematology, and oncology. She is an instructor in the Stanford School of Medicine Department of Medicine, Division of Blood & Marrow Transplantation and Cellular Therapy.

    Dr. Bharadwaj focuses her expertise on diagnosing and treating cancer in blood and bone marrow. For each patient, she develops a personalized, comprehensive, and compassionate care plan. In her diverse experience as a physician and scientist, she has served as an internal medicine doctor, hospitalist, hematologist, oncologist, and blood and marrow transplantation specialist. Dr. Bharadwaj has a degree in clinical research and is currently conducting clinical trials in transplant and cellular therapy.

    She has participated in research studies of advances in therapy for chronic lymphocytic leukemia, melanoma, and breast cancer. She has co-authored articles published in Leukemia and Lymphoma and elsewhere. Topics include advances in cell transplantation. She also co-wrote the chapter on genome-driven personalized cancer therapy in the book Precision Medicine in Oncology.

    Dr. Bharadwaj has made presentations at meetings of the American Society of Hematology, American Society of Clinical Oncology, and other associations.
    Subjects include racial, demographic, and socioeconomic disparities in the treatment of patients with acute myeloid leukemia.

    Dr. Bharadwaj is a member of the American Society for Transplantation and Cellular Therapy, American Society of Hematology, and American Society of Clinical Oncology.

  • Mahendra T. Bhati

    Mahendra T. Bhati

    Clinical Professor, Psychiatry and Behavioral Sciences
    Clinical Professor, Neurosurgery

    BioDr. Bhati is an interventional psychiatrist with expertise in psychiatric diagnosis, psychopharmacology, and neuromodulation. He completed postdoctoral research studying language abnormalities and transcranial magnetic stimulation (TMS) evoked potentials in schizophrenia. He was a principal investigator for the DSM-5 academic field trials, and his research experiences included roles in the first controlled clinical trials of TMS and deep brain stimulation (DBS) for treatment of depression. He was the founding Chief of Interventional Psychiatry at Stanford where he performs consultations and provides pharmacological and neuromodulatory treatments. His current research interests include studying magnetic resonance imaging and augmented reality to target TMS, vagus nerve stimulation (VNS) for treatment-resistant depression, DBS for obsessive-compulsive disorder (OCD) and depression, responsive neurostimulation (RNS) for treatment of impulse and fear-related disorders, and focused ultrasound (FUS) for treatment-resistant OCD and depression. Dr. Bhati seeks to train more providers in mental healthcare and founded a clinical fellowship in Interventional Psychiatry at Stanford.

  • Richa Bhatia, MD

    Richa Bhatia, MD

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    BioDr. Bhatia is a Distinguished Fellow of the American Psychiatric Association and Clinical Associate Professor in the Department of Psychiatry at Stanford University School of Medicine. She is a dual Board-certified child, adolescent and adult psychiatrist with nearly two decades of clinical experience caring for patients with various psychiatric conditions. She leads the adult anxiety clinic at Stanford. Her work has been cited in Time magazine, Scientific American, and the Atlantic, and her professional opinions have been quoted in media such as CNBC, The Guardian, U.S. News and World Report, The Wall Street Journal, and others. Dr. Bhatia served as President-Elect of Northern California Psychiatric Society and is Immediate Past President of the Association of Women Psychiatrists. She is the co-author of the chapter on Obsessive Compulsive and Related Disorders in the recent Study Guide to DSM-5 TR, a companion volume to DSM-5 TR. She is a public mental health educator and for her work in this arena, she was honored with the 2021 Jerilyn Ross Clinician Advocate Award by the Anxiety and Depression Association of America. She has also been a recipient of the Marian Butterfield award. Her other roles include serving as Section Editor for Current Opinion in Psychiatry, a Wolters Kluwer journal, for the last 8 years. She also served as Associate Editor of Current Psychiatry for 6 years. She is often invited to give talks at national, regional and local conferences and organizations.

    She takes a whole-person approach, utilizing active, empathic listening and aimed at understanding the biological, psychological, social, and other factors affecting an individual’s mental health. She integrates judicious medication management with psychotherapy. Her psychotherapy approach is informed by various evidence-based psychotherapies such as psychodynamic therapy, cognitive behavioral therapy, and mindfulness-based, self-compassion-focused interventions. Dr. Bhatia’s other professional interests include ruling out medical conditions mimicking anxiety and other psychiatric disorders, the intersection of technology and mental health, bullying prevention, and compassion and empathy cultivation- she has also authored publications on these topics.

  • Ritwik Bhatia, MD

    Ritwik Bhatia, MD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Bhatia is a board-certified, fellowship-trained neurologist with Stanford Health Care and a clinical assistant professor in the Department of Neurology and Neurological Sciences, Division of Neurocritical Care at Stanford University School of Medicine.

    Dr. Bhatia joined Stanford in 2024 after completing Neurocritical Care fellowship at the University of California, San Francisco. He provides critical care to patients following acute neurological injuries, such as stroke, traumatic brain injury, intracranial hemorrhage, and other disorders affecting the brain, spinal cord, and nervous system. He strives to provide excellent patient care in multidisciplinary teams. He enjoys teaching and is the physician lead for simulation for Advanced Practice Providers in Neurocritical Care. He currently serves as the Unit Based Medical Director for the Neurosciences ICU at Stanford Hospital, leading the unit's initiatives in quality and patient safety.

    Dr. Bhatia’s research interests include longitudinal outcomes for patients with moderate-severe acute acquired brain injury requiring intensive care unit admission. He is developing a neurointensive care recovery clinic at Stanford Healthcare to follow these patients through transitions of care and support neurorecovery.

    Dr. Bhatia has published in several peer-reviewed journals, including Neurology, Journal of Neurosurgery, and Stroke. He has presented at national meetings for the American Academy of Neurology, Society of Vascular and Interventional Neurology, and American Epilepsy Society. He has served as a guideline ambassador for the American Heart Association and is a member of the Neurorecovery Clinic Section of the Neurocritical Care Society. In his spare time, he enjoys spending time with family and friends.

  • Ami Bhatt

    Ami Bhatt

    Professor of Medicine (Hematology) and of Genetics

    Current Research and Scholarly InterestsThe Bhatt lab is exploring how the microbiota is intertwined with states of health and disease. We apply the most modern genetic tools in an effort to deconvolute the mechanism of human diseases.

  • Apurva Bhatt

    Apurva Bhatt

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioApurva Bhatt, M.D., is a child, adolescent and adult psychiatrist and Clinical Assistant Professor at Stanford University School of Medicine. Her role spans the General Adult Psychiatry Division, Child Psychiatry Division, and Center for Youth Mental Health and Wellbeing.

    Dr. Bhatt specializes in early psychosis evaluation and treatment. She is the Director of the Child INSPIRE clinic and currently provides clinical care in both the Stanford Children’s Hospital Child INSPIRE early psychosis clinic and the Stanford Health Care INSPIRE clinic and INSPIRE360 Coordinated Specialty Care/Wraparound program. She contributes to early psychosis program development in California (through EPI-CAL as the Psychiatric Provider Team Lead) and nationally (through PEPPNET). She is also co-chair of the American Academy of Child and Adolescent Psychiatry Adolescent Psychiatry Committee and Early Psychosis work group.

    Dr. Bhatt is also a school psychiatrist, providing school clinical consultations for the Redwood City School District through the Stanford Redwood City Sequoia School Mental Health Collaborative. She also provides clinical consultations to schools in the Los Altos School district, and supervises child and adolescent psychiatry fellows providing consultation to Los Altos, Redwood City, and Mountain View schools.

    Dr. Bhatt’s research interests include Asian American and South Asian youth mental health and prevention of youth suicide. She enjoys teaching and mentoring students and trainees, and currently is a mentor through the American Academy of Child and Adolescent Psychiatry.

  • Hilarey Ransom Bhatt

    Hilarey Ransom Bhatt

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioDr. Bhatt is an expert clinician, educator, and health system leader in the specialty of internal medicine. She earned her MD from University of California San Francisco School of Medicine and completed her training at UCSF’s Internal Medicine residency program. Dr. Bhatt is certified by the American Board of Internal Medicine. Dr. Bhatt cares for people ages 18 and up. She practices at Stanford Express Care in Palo Alto and San Jose, where she serves as the Medical Director of the clinic. She has a particular interest in the care of medically complex patients and in teaching and practicing evidence-based medicine. She believes that the patient-clinician relationship is the foundation of good care and strives to develop respectful and collaborative relationships with all her patients.

  • Jayanta Bhattacharya

    Jayanta Bhattacharya

    Professor of Health Policy, Emeritus

    Current Research and Scholarly InterestsMy research focuses on the constraints that vulnerable populations face in making decisions that affect their health status, as well as the effects of government policies and programs designed to benefit vulnerable populations.

  • Achintya K. Bhowmik, PhD

    Achintya K. Bhowmik, PhD

    Adjunct Professor, OHNS/Otology & Neurotology Division

    BioDr. Achin Bhowmik serves on the faculty of Stanford University as an adjunct professor at the Stanford School of Medicine, where he advises research and lectures in the areas of sensory augmentation, computational perception, cognitive neuroscience, and intelligent systems. He is also an affiliate faculty member of the Stanford Institute for Human-Centered Artificial Intelligence, Wu Tsai Neurosciences Institute and Human Performance Alliance, and a mentor for the Stanford Institutes of Medicine Summer Research Program.

    Dr. Bhowmik is the chief technology officer and executive vice president of engineering at Starkey Hearing Technologies, a privately-held medical devices company with over 5,000 employees and operations in over 100 countries worldwide. In this role, he is responsible for the company’s technology strategy, research and development, engineering and program management departments, and leading the drive to transform hearing aids into multifunction wearable health and communication devices with advanced sensors and artificial intelligence.

    Previously, Dr. Bhowmik was the vice president and general manager of the Perceptual Computing Group at Intel Corporation, where he was responsible for the R&D, engineering, operations, and businesses in the areas of 3D sensing and interactive computing, computer vision and artificial intelligence, autonomous robots and drones, and immersive virtual and merged reality devices.

    Dr. Bhowmik is a member of the Forbes Technology Council, board of trustees for the National Captioning Institute, board of directors for Mojo Vision and OpenCV, board of advisors for the Fung Institute for Engineering Leadership at the University of California, Berkeley, and industry advisory board for the Institute for Engineering in Medicine and Biomedical Engineering at the University of Minnesota. He is also on the board of advisors for several technology startup companies.

    He has also held adjunct and guest professor positions at the University of California, Berkeley, Liquid Crystal Institute of the Kent State University, Kyung Hee University, Seoul, and the Indian Institute of Technology, Gandhinagar. He received his Bachelor of Technology from the Indian Institute of Technology, Kanpur, PhD from Auburn University, and attended the Executive Program at Stanford University. He has authored over 200 publications, including two books and over 80 granted patents.

    His awards and honors include Fellow of the Institute of Electrical and Electronics Engineers (IEEE), President and Fellow of the Society for Information Display (SID), Fellow of the Asia-Pacific Artificial Intelligence Association (AAIA), Artificial Intelligence Excellence award by the Business Intelligence Group, Gold Globee award for “Most Innovative Person of the Year in Healthcare”, Top 25 Healthcare Technology CTOs by the Healthcare Technology Report, Notable Leaders in Healthcare by Twin Cities Business, Healthcare Heroes award by the Business Journals, Industrial Distinguished Leader award from the Asia-Pacific Signal and Information Processing Association, TIME’s Best Inventions, and the Red Dot Design award.

    Dr. Bhowmik and his work have been covered in numerous press articles, including TIME, Fortune, Wired, USA Today, US News & World Reports, Wall Street Journal, CBS News, BBC, Forbes, Bloomberg Businessweek, Scientific American, Popular Mechanics, MIT Technology Review, EE Times, The Verge, etc.

  • Nidhi Bhutani

    Nidhi Bhutani

    Associate Professor of Orthopaedic Surgery

    Current Research and Scholarly InterestsThe long-term goal of our research is to understand the fundamental mechanisms that govern and reprogram cellular fate during development, regeneration and disease.

  • Vinod (Vinny) K. Bhutani

    Vinod (Vinny) K. Bhutani

    Professor of Pediatrics (Neonatology) at the Lucile Salter Packard Children's Hospital, Emeritus

    Current Research and Scholarly InterestsNeonatology; newborn jaundice, bilirubin biology and kernicterus prevention; pulmonary physiology, pulmonary functions and neonatal ventilation. To promote newborn screening for G6PD deficiency in USA.